Leaderboard

En | De
No articles selected!     View Cart  
You are here: Gastroenterology » Liver » Neoplasms 03. November 2025
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3672  Previews Next
   
   Articles 1 - 20 / 73423  
   
Towards a personalized utilization of stereotactic body radiotherapy for the management of liver metastases in solid tumors.
Cancer Metastasis Rev
Laurent PA, Ka K, Roulleaux Dugage M, Levy A, Bahleda R, Durand-Labrunie J, Massard C, Deutsch E, Sun R.
PMID: 41175290 [PubMed - indexed for MEDLINE]


Clinicopathological significance of AKT and phosphorylated AKT expression in hepatocellular carcinoma: A Meta-Analysis.
BMC Cancer
Ma Y, Chen M, Xu Z.
PMID: 41174612 [PubMed - indexed for MEDLINE]


Efficacy and safety of DEB-TACE combined with HAIC and donafenib in the treatment of unresectable hepatocellular carcinoma: a dual-center retrospective study.
BMC Cancer
Zhang X, Fang X, Wang R, Xiong B, Long J, Guo Q, Chu M, Luo W, Shi S.
PMID: 41174543 [PubMed - indexed for MEDLINE]


A Higher Risk of Liver Cancer in Alcoholic Fatty Liver Disease than in Non-Alcoholic Fatty Liver Disease: an Analysis of the TriNetX Dabatase.
J Gastrointest Cancer
Chang LH, Su SY, Lee C, Hsu CY.
PMID: 41171519 [PubMed - indexed for MEDLINE]


Chemoprevention of hepatocellular carcinoma.
Hepatol Commun
Schwenk S, Kaplan DE.
PMID: 41171441 [PubMed - indexed for MEDLINE]


Development and evaluation of a nutritional risk prediction model for patients with hepatocellular carcinoma undergoing transarterial chemoembolisation.
Clin Exp Med
Chen CX, Chen XF, Wang TL, Gu HY, Xu GH, Cui ZM.
PMID: 41171346 [PubMed - indexed for MEDLINE]


First-line immune checkpoint inhibitors plus targeted therapy versus sorafenib or lenvatinib monotherapy for unresectable or advanced hepatocellular carcinoma: a meta-analysis of phase 3 trials.
Front Immunol
Lin Y, Liao Y, Luo B, Shen J.
PMID: 41169385 [PubMed - indexed for MEDLINE]


Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma.
Front Immunol
Zhong F, Yao F, Wang XL, Wang Z, Huang B, Liu J, Wang X, Zhang L.
PMID: 41169384 [PubMed - indexed for MEDLINE]


Immunological aspects of naturally occurring model of hepatitis B virus (HBV) infection, hepatitis B, and HBV-associated hepatocellular carcinoma in the American woodchuck Marmota monax.
J Immunol
Michalak TI.
PMID: 41169234 [PubMed - indexed for MEDLINE]


Epidemiological Profile of Hepatocellular Carcinoma in Brazil.
In Vivo
DA Rocha RR, Martins MR, DE Melo LWP, Dos Santos RL, Torres LC, Thuler LCS, Costa GJ.
PMID: 41167688 [PubMed - indexed for MEDLINE]


Nanomaterial-assisted immunodiagnostic profiling and therapeutic targeting of hepatocellular carcinoma: from molecular biomarkers to clinical applications.
Front Immunol
Luo J, Ye J, Huang K, Cheng Z, Liu L, Li X.
PMID: 41164201 [PubMed - indexed for MEDLINE]


Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk.
Front Immunol
Ma Z, Wang S, Liu S, Yang W, Hu J, Lv L, Yu Q, Lu Y.
PMID: 41164182 [PubMed - indexed for MEDLINE]


Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study.
Eur J Med Res
Bi F, Qin S, Gu S, Bai Y, Chen Z, Wang Z, Ying J, Lu Y, Meng Z, Pan H, Yang P, Zhang H, Chen X, Xu A, Cui C, Zhu B, Wu J, Xin X, Wang J, Shan J, Chen J, Zheng Z, Xu L, Wen X, You Z, Ren Z, Xu J, Du C, Fan Q, Zhang L, Tao M, Jiang D, Wang S, Chen Y, Sheng J, Zhuang X, Wu J.
PMID: 41163129 [PubMed - indexed for MEDLINE]


The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study.
J Hematol Oncol
Guo D, Huang A, Sun J, Zhang S, Cheng J, Jiang R, Wang Y, Chen H, Zhang F, Peng J, Yuan J, Wang J, Guo H, Chen Z, Chen Y, Chen X, Zhu S, Fan J, Wang Y, Yang X, Zhou J.
PMID: 41163059 [PubMed - indexed for MEDLINE]


The Ubiquitin-Proteasome System in Hepatitis B Virus Infection and Hepatocarcinogenesis: Viral Manipulation and Therapeutic Targets.
J Microbiol Biotechnol
Han J, Kim KH, Seo SU.
PMID: 41162171 [PubMed - indexed for MEDLINE]


Ultrasounic-radiomics models for predicting the response to Atezolizumab plus Bevacizumab in patients with unresectable hepatocellular carcinoma.
PLoS One
Li Y, Liu Z, Qian Y, Wang K, Gu Y, Chen Y, Jiang H, Cheng S, Jiang D.
PMID: 41160615 [PubMed - indexed for MEDLINE]


Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases.
Cancer Metastasis Rev
Cunanan CJ, Sanders AB, Gallant KC, Seedor RS, Hartsough EJ.
PMID: 41160198 [PubMed - indexed for MEDLINE]


Machine learning algorithms for individualized prediction of prognosis in breast cancer liver metastases and the prognostic impact of primary tumor surgery: a multicenter study.
Front Endocrinol (Lausanne)
Chen C, Wu J, Xu B, Li W, Zhong C, Yan Z, Zhong Q, Li R, Shao M, Dong Y, Fang Y, Li Y, Zhang Q.
PMID: 41158637 [PubMed - indexed for MEDLINE]


Research Progress on Quinone Compounds for the Treatment of Hepatocellular Carcinoma.
Biomolecules
Ye Y, Liu M, Miao Y, Pei K, Lin Z, Liu S, Huang X, Wang Y, Lv G.
PMID: 41154629 [PubMed - indexed for MEDLINE]


Effect of disappearing liver metastases during pre-ablation chemotherapy on the prognosis of percutaneous microwave ablation in synchronous colorectal liver metastases patients.
Cancer Imaging
Chen L, Zhou J, Cui R, Qin S, Chen Y, Wang Y, Liu G.
PMID: 41153064 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 73423    Page 1 of 3672  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1